MedTrace Logo

Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG

NCT06378021 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-04-22

No results posted yet for this study

Summary

This study hypothesize that injecting calcium chloride (CaCl2) into the major atrial ganglionated plexus (GPs) during on pump Coronary artery bypass graft (CABG) can reduce the incidence of Post operative Atrial fibrillation in the first 7 days after surgery.The study is designed to be prospective interventional study two armed RCT for on pump CABG patient.

The intervention arm will be injected with Calcium chloride in the four major atrial ganglionic plexus The control arm will be injected with sodium chloride to determine the effect of Calcium chloride on Post CABG Atrial fibrillation

Conditions

Interventions

DRUG

Calcium Chloride

5 % calcium chloride injection in cardiac ganglionic Plexus during On pump Coronary artery bypass graft

DRUG

Sodium Chloride 0.9% Inj

0.9% sodium chloride injection during on pump during Coronary artery bypass graft

Sponsors & Collaborators

  • Helwan University

    lead OTHER

Principal Investigators

  • Abdelhameed I Ebid · Prof

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-14
Primary Completion
2025-03-31
Completion
2025-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06378021 on ClinicalTrials.gov